Edward van der Horst
2022
In 2022, Edward van der Horst earned a total compensation of $654.4K as Chief Scientific Officer at Sensei Biotherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $103,543 |
|---|---|
| Option Awards | $146,327 |
| Salary | $326,923 |
| Stock Awards | $63,210 |
| Other | $14,401 |
| Total | $654,404 |
der Horst received $326.9K in salary, accounting for 50% of the total pay in 2022.
der Horst also received $103.5K in non-equity incentive plan, $146.3K in option awards, $63.2K in stock awards and $14.4K in other compensation.
Rankings
In 2022, Edward van der Horst's compensation ranked 3,907th out of 5,760 executives tracked by ExecPay. In other words, der Horst earned more than 32.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,907 out of 5,760 | 32nd |
Division Manufacturing | 2,209 out of 3,136 | 30th |
Major group Chemicals And Allied Products | 1,070 out of 1,422 | 25th |
Industry group Drugs | 1,004 out of 1,323 | 24th |
Industry Pharmaceutical Preparations | 736 out of 969 | 24th |
Source: SEC filing on June 15, 2023.
der Horst's colleagues
We found three more compensation records of executives who worked with Edward van der Horst at Sensei Biotherapeutics in 2022.